TrialPanorama/TrialPanorama-database huggingface dataset:
Study 22385260 — Predictive Biomarker (PRD): LRIT1 mRNA
Genes: LRIT1; LRRC21; PAL
Study 19048594 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 15181067 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 3706675 — Surrogate Endpoint (SUR): Forced vital capacity
Study 27213735 — Surrogate Endpoint (SUR): Blood pressure
Study 24151982 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study 24151982 — Surrogate Endpoint (SUR): Forced vital capacity
Study 20971614 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 16908486 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 16908486 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 15114598 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 11710402 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 9020286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 9020286 — Surrogate Endpoint (SUR): Serum testosterone
Study 3297732 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29245259 — Surrogate Endpoint (SUR): Blood pressure
Study 23507773 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 21554245 — Predictive Biomarker (PRD): KLRG1 mRNA
Genes: KLRG1; CLEC15A; MAFA; MAFAL
Study 21554245 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study 15816266 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 12575585 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9040055 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 27632917 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16188920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26440134 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 24140664 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 1994935 — Surrogate Endpoint (SUR): Blood pressure
Study 20646010 — Surrogate Endpoint (SUR): Blood pressure
Study 9088586 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 9088586 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 9088586 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 20923370 — Safety Biomarker (SAF): Interleukin 12
Study 1350264 — Safety Biomarker (SAF): Hypoxanthine-guanine phosphoribosyltransferase
Genes: HPRT1; HPRT
Study 6756932 — Surrogate Endpoint (SUR): Blood pressure
Study 30817733 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24672936 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24672936 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 22051941 — Surrogate Endpoint (SUR): Blood pressure
Study 22051941 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26141671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26141671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26141671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16893754 — Surrogate Endpoint (SUR): Blood pressure
Study 1900384 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1900384 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 6829485 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 31797522 — Surrogate Endpoint (SUR): Blood pressure
Study 23678038 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 23678038 — Surrogate Endpoint (SUR): Bone mineral density
Study 23678038 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16365322 — Surrogate Endpoint (SUR): Blood pressure
Study 28387895 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 28387895 — Surrogate Endpoint (SUR): Blood pressure
Study 25940902 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study 11435263 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 23463857 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study 23463857 — Predictive Biomarker (PRD): NFIA mRNA
Genes: NFIA; KIAA1439
Study 23463857 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study 7993600 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 24785954 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24785954 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 15138837 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15138837 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 12474070 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12474070 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12474070 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 2141773 — Surrogate Endpoint (SUR): Blood pressure
Study 91901 — Surrogate Endpoint (SUR): Blood pressure
Study 27798731 — Surrogate Endpoint (SUR): Blood pressure
Study 27798731 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25873267 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 23813302 — Surrogate Endpoint (SUR): Blood pressure
Study 10085713 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 18291396 — Surrogate Endpoint (SUR): Blood pressure
Study 8228191 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8228191 — Surrogate Endpoint (SUR): Blood pressure
Study 27503012 — Surrogate Endpoint (SUR): Serum uric acid
Study 27503012 — Surrogate Endpoint (SUR): Serum creatinine
Study 27503012 — Surrogate Endpoint (SUR): Blood pressure
Study 12475469 — Surrogate Endpoint (SUR): Blood pressure
Study 28096254 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9049577 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11581005 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11581005 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29958916 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 12814449 — Surrogate Endpoint (SUR): Serum creatinine
Study 1644095 — Surrogate Endpoint (SUR): Blood pressure
Study 18399341 — Surrogate Endpoint (SUR): Blood pressure
Study 28719039 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 21232112 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15758560 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 15758560 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 11549686 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9039927 — Surrogate Endpoint (SUR): Bone mineral density
Study 7895587 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 3285117 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 23873632 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 23873632 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 23873632 — Surrogate Endpoint (SUR): Bone mineral density
Study 23981616 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 23981616 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 25675380 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15019868 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 15019868 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 15019868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8748411 — Surrogate Endpoint (SUR): Serum creatinine
Study 10190648 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 10190648 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 10190648 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 10190648 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 24561814 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24561814 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 22330085 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 21388056 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29503163 — Predictive Biomarker (PRD): MEGF10 mRNA
Genes: MEGF10; KIAA1780
Study 29503163 — Predictive Biomarker (PRD): SLC1A1 mRNA
Genes: SLC1A1; EAAC1; EAAT3; HEAAC1
Study 29503163 — Predictive Biomarker (PRD): PCDH7 mRNA
Genes: PCDH7; BHPCDH
Study 29503163 — Predictive Biomarker (PRD): CNTNAP5 mRNA
Genes: CNTNAP5; CASPR5
Study 29503163 — Predictive Biomarker (PRD): TNIK mRNA
Genes: TNIK; KIAA0551
Study 29503163 — Predictive Biomarker (PRD): CACNA1C mRNA
Genes: CACNA1C; CACH2; CACN2; CACNL1A1; CCHL1A1
Study 29503163 — Predictive Biomarker (PRD): CNTN4 mRNA
Genes: CNTN4
Study 8129455 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 28927890 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 28927890 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 28927890 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study 28927890 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23070986 — Surrogate Endpoint (SUR): Blood pressure
Study 21943218 — Surrogate Endpoint (SUR): Serum sodium
Study 10738581 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 17143493 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 17143493 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 9658724 — Predictive Biomarker (PRD): PSMB6 mRNA
Genes: PSMB6; LMPY; Y
Study 2501094 — Surrogate Endpoint (SUR): Blood pressure
Study 4179167 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 21816918 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 9060881 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 25527749 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21944667 — Surrogate Endpoint (SUR): Serum creatinine
Study 21944667 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 24595631 — Surrogate Endpoint (SUR): Blood pressure
Study 15631531 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15631531 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20492060 — Surrogate Endpoint (SUR): Blood pressure
Study 31915046 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31915046 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 23039340 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 9257763 — Surrogate Endpoint (SUR): Serum creatinine
Study 30354362 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 15655101 — Surrogate Endpoint (SUR): Blood pressure
Study 7446943 — Surrogate Endpoint (SUR): Blood pressure
Study 20377818 — Predictive Biomarker (PRD): DHDDS mRNA
Genes: DHDDS; HDS
Study 2643773 — Surrogate Endpoint (SUR): Blood pressure
Study 17346614 — Surrogate Endpoint (SUR): Blood pressure
Study 2491863 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 28168715 — Predictive Biomarker (PRD): CCR1 mRNA
Genes: CCR1; CMKBR1; CMKR1; SCYAR1
Study 25835462 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8329676 — Surrogate Endpoint (SUR): Blood pressure
Study 25169488 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25169488 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 23195004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30009473 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PENK mRNA
Genes: PENK
Study 30009473 — Surrogate Endpoint (SUR): Serum creatinine
Study 12798527 — Surrogate Endpoint (SUR): Blood pressure
Study 28781336 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 28781336 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 11009046 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 11009046 — Safety Biomarker (SAF): Alpha-glutathione S-transferase
Study 10569324 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30137410 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30137410 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 17508971 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 9797945 — Predictive Biomarker (PRD): SPIN1 mRNA
Genes: SPIN1; OCR; SPIN
Study 26715479 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22030225 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29466057 — Surrogate Endpoint (SUR): Bone mineral density
Study 17595194 — Surrogate Endpoint (SUR): Blood pressure
Study 30251330 — Surrogate Endpoint (SUR): Blood pressure
Study 15880608 — Monitoring Biomarker (MOI): HBV DNA
Study 10477209 — Surrogate Endpoint (SUR): Blood pressure
Study 19524285 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 17470020 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 17470020 — Predictive Biomarker (PRD): APELA mRNA
Genes: APELA; ELA; TDL
Study 28062315 — Surrogate Endpoint (SUR): Bacterial count
Study 11266032 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 30583852 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 24548796 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 19574612 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 17342169 — Surrogate Endpoint (SUR): Blood pressure
Study 17342169 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 7532319 — Safety Biomarker (SAF): Interleukin 1
Study 7532319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 7532319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7532319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 3442182 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study 23973688 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23973688 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17308269 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 14770192 — Predictive Biomarker (PRD): ERF mRNA
Genes: ERF
Study 14770192 — Surrogate Endpoint (SUR): Blood pressure
Study 30763939 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30763939 — Surrogate Endpoint (SUR): Serum triglycerides
Study 30763939 — Surrogate Endpoint (SUR): Blood pressure
Study 30763939 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30573476 — Surrogate Endpoint (SUR): Blood pressure
Study 25159818 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 19240522 — Safety Biomarker (SAF): Hyaluronic acid
Study 6927816 — Surrogate Endpoint (SUR): Blood pressure
Study 30119284 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30119284 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27467027 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 20860128 — Surrogate Endpoint (SUR): Bone mineral density
Study 19088847 — Predictive Biomarker (PRD): EBPL mRNA
Genes: EBPL; EBRP; ERP
Study 22758620 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 12351250 — Surrogate Endpoint (SUR): Forced vital capacity
Study 9440727 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 31928506 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 25046847 — Monitoring Biomarker (MOI): HBV DNA
Study 16613276 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 23571179 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 19489129 — Surrogate Endpoint (SUR): Serum potassium
Study 30300282 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 8289409 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 8289409 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21062338 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 17213274 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study 11678487 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 2589534 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 2589534 — Predictive Biomarker (PRD): ANTXR1 mRNA
Genes: ANTXR1; ATR; TEM8
Study 19170852 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 23405070 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 23405070 — Surrogate Endpoint (SUR): Blood pressure
Study 19054193 — Surrogate Endpoint (SUR): Blood pressure
Study 16907703 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study 16907703 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study 16907703 — Predictive Biomarker (PRD): ADRA2B mRNA
Genes: ADRA2B; ADRA2L1; ADRA2RL1
Study 21175704 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 3571753 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 18959492 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10912845 — Surrogate Endpoint (SUR): Bone mineral density
Study 24617961 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 20692282 — Surrogate Endpoint (SUR): Blood pressure
Study 10333196 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study 29803590 — Surrogate Endpoint (SUR): Blood pressure
Study 21750964 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 16205449 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 16205449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16205449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1669237 — Predictive Biomarker (PRD): CAST mRNA
Genes: CAST
Study 9584497 — Surrogate Endpoint (SUR): Bone mineral density
Study 26829012 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2547540 — Safety Biomarker (SAF): Hyaluronic acid
Study 2547540 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 2547540 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 30541365 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30541365 — Surrogate Endpoint (SUR): Blood pressure
Study 21138634 — Monitoring Biomarker (MOI): HBV DNA
Study 12694432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12694432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12694432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11127527 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 29526681 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study 18443775 — Predictive Biomarker (PRD): EEF1A2 mRNA
Genes: EEF1A2; EEF1AL; STN
Study 9951426 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 7752176 — Surrogate Endpoint (SUR): Blood pressure
Study 23710811 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 23710811 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 3623815 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 19880429 — Predictive Biomarker (PRD): TAC1 mRNA
Genes: TAC1; NKA; NKNA; TAC2
Study 16309383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16309383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16309383 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 11157012 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 26408054 — Surrogate Endpoint (SUR): Blood pressure
Study 26408054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24308693 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 16696910 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 16696910 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16696910 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 15002082 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11697808 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 28785895 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 12662126 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 12121503 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 29482528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25415673 — Surrogate Endpoint (SUR): Bone mineral density
Study 20032785 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol